Molecular analysis of in vivo hprt mutations in human T lymphocytes. V. Effects of total body irradiation secondary to radioimmunoglobulin therapy (RIT)
Molecular analysis of in vivo hprt mutations in human T lymphocytes. V. Effects of total body irradiation secondary to radioimmunoglobulin therapy (RIT)
复制标题
人 T 淋巴细胞体内 hprt 突变的分子分析。
DOI:
10.1093/mutage/5.5.461
复制
发表时间:
1990
期刊:
影响因子:
2.7
通讯作者:
Albertini,RJ
中科院分区:
文献类型:
--
作者:
Nicklas,JA;Falta,MT;Hunter,TC;O'Neill,JP;Jacobson-Kram,D;Williams,JR;Albertini,RJ
Thehprt(hypoxanthine guanine phosphoribosyltransferase) T cell cloning assay was used to detectin vivomutations in T lymphocytes of individuals receiving radioimmunoglobulin therapy (RIT). A total of 28 patients receiving131I and/or90Y-labeled antiferritin antibodies was studied. Mutant frequencies for patients were clearly much higher than for historic non-treated controls (median 68.0×10−6for patients versus a median of 6.8×10−6for 115 controls). There was a good correlation of mutant frequency with initial activity of RIT (rlinear= 0.68,rquadratic= 0.76;P<0.05) although the correlation of mutant frequency with total activity after several rounds of treatment was poor (R=0.18). Molecular studies of the hprt mutants demonstrated that a much higher proportion of mutations occurring in RIT treated patients had gross structural alterations of the hprt gene (33%) than did mutations occurring in controls (15%). There was a good correlation (r=0.72) of mutants with gross alterations and total RIT activity. T cell receptor gene studies demonstrated that most of the mutants (92%) represented independentin vivomutations, which is similar to previous findings with background mutations in non-irradiated individuals. These studies demonstrate the usefulness of thehprtT cell cloning assay for studies ofin vivohuman somatic cell gene mutations resulting from ionizing radiation.